Preventing and Managing Heart Failure – One Size Does Not Fit All
Biykem Bozkurt, MD

PCSK9 Inhibitors Today – When, How, and In Whom
Jennifer Robinson, MD

Coronary Risk Assessment in Women: What Works?
Martha Gulati, MD

Achieving Blood Pressure Controls in Your Clinic – Strategies for Success
Lynn Braun, PhD

Managing Blood Pressure in Special Populations
Keith Ferdinand, MD

Role of SGLT2/GLP1 Agents in a Preventive Cardiologist’s Practice, A Seminal Transition in DM Management
Mikhail Kosiborod, MD

Comprehensive Approach to Lowering CVD Risk in Diabetics
Yehuda Handelsman, MD

Differentiating Antiplatelet Agents
Peter Toth, MD, PhD

Time to Re-Think Triglyceride Lowering-ANGPTL3, ApoC3 and Beyond
Seth Baum, MD

AHA/ACC 2017 Hypertension Guidelines Update
William Cushman, MD

Charting New Territory – Inflammation as a CVD Target
Christie Ballantyne, MD

Update on FH and the FIND FH Initiative
Christine Ballantyne, MD

Genetics in CVD Prevention: Insights and Opportunities
Sekar Kathiresan, MD

Dietary Fats and CVD – Calming the Controversy
Jo Ann Carson, MD

Nanette Wegner Lecture 2018 – Go Red for Women: What a Difference a Movement Makes
Lori Mosca, MD